Credential Qtrade Securities’s Vertex Pharmaceuticals VRTX Stock Holding History

Credential Qtrade Securities’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$365K	Sell	872 -188	-18%	-$79.5K	0.02%	215
2023 Q4	$431K	Sell	1,060 -59	-5%	-$21.8K	0.03%	188
2023 Q3	$389K	Sell	1,119 -15	-1%	-$5.25K	0.03%	188
2023 Q2	$399K	Sell	1,134 -29	-2%	-$9.77K	0.03%	191
2023 Q1	$366K	Sell	1,163 -43	-4%	-$12.9K	0.02%	203
2022 Q4	$348K	Sell	1,206 -8	-0.7%	-$2.44K	0.03%	208
2022 Q3	$352K	Buy	1,214 +48	+4%	+$13.8K	0.03%	189
2022 Q2	$329K	Sell	1,166 -1,837	-61%	-$492K	0.02%	201
2022 Q1	$784K	Buy	3,003 +55	+2%	+$13.1K	0.05%	153
2021 Q4	$647K	Buy	+2,948	New	+$573K	0.04%	176

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Credential Qtrade Securities's VRTX Position: Q1 2024 in Review

Credential Qtrade Securities reduced its Vertex Pharmaceuticals (VRTX) stake by 18% in Q1 2024, selling an estimated $79.5K and leaving 872 shares worth $365K. The position accounts for 0.02% of the portfolio, ranked #215.

Credential Qtrade Securities first reported a position in VRTX in Q4 2021 and has held it in 10 quarters since. The position peaked at $784K in Q1 2022. 1,495 funds tracked by Wall St. Rank hold VRTX as of Q1 2024.

Credential Qtrade Securities held 872 shares of Vertex Pharmaceuticals worth $365K as of Q1 2024.
Credential Qtrade Securities sold 188 Vertex Pharmaceuticals shares in Q1 2024, an estimated $79.5K.
Vertex Pharmaceuticals made up 0.02% of Credential Qtrade Securities's portfolio in Q1 2024, its #215 holding.
Credential Qtrade Securities first reported a position in Vertex Pharmaceuticals in Q4 2021 and has held it in 10 quarters since.
Credential Qtrade Securities's Vertex Pharmaceuticals position peaked at $784K in Q1 2022.
1,495 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2024.

Based on Credential Qtrade Securities's 13F filing for Q1 2024, filed 21 Jul 2025.